Microalbuminuria is not associated with endothelial dysfunction and coronary atherosclerosis in patients with acute coronary syndromes

Renal Failure

Volumn 32, Issue 6, 2010, Pages 659-665

  Duran, Mustafa ^a   Kalay, Nihat ^b   Ardic, Idris ^b   Yarlioglues, Mikail ^b   Kayaalti, Fatma ^b   Yilmaz, Ycel ^b   Akpek, Mahmut ^b   Kaya, Mehmet Gungor ^b   Topsakal, Ramazan ^b  

^a MINISTRY OF HEALTH   (Turkey)

^b ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Acute coronary syndrome; Coronary atherosclerosis; Endothelial dysfunction; Flow mediated dilatation; Microalbuminuria

Indexed keywords

GLYCERYL TRINITRATE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ALBUMIN BLOOD LEVEL; ALBUMINURIA; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORPHOLOGY; PRIORITY JOURNAL; SCORING SYSTEM; VASODILATATION; VEIN DILATATION;

ACUTE CORONARY SYNDROME; ALBUMINURIA; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 77953554751     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.485288     Document Type: Article

References (39)

1. Jarrett RG, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrels TJ. Microalbuminuria predicts mortality in non-IDD. Diabet Med. 1984;1:17-19.
2. Hillege HL, Janssen WM, Bak AA, et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med. 2001;249: 519-526.
3. Schmitz A, Vaeth M. Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabet Med. 1988;5:126-134.
4. Lekatsas I, Koulouris S, Triantafyllou K, et al. Prognostic significance of microalbuminuria in non-diabetic patients with acute myocardial infarction. Int J Cardiol. 2006;106: 218-223.
5. Geluk CA, Tio RA, Tijssen JG, et al. Clinical characteristics, cardiac events and coronary angiographic findings in the prospective PREVEND cohort: An observational study. Neth Heart J. 2007;15:133-141.
6. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelium-dependent flowmediated vasodilation of the brachial artery: A report of the international brachial artery reactivity task force. J Am Coll Cardiol. 2002;39:257-265.
7. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr., Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101:948-954.
8. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899-1906.
9. Hammermeister KE, DeRouen TA, Dodge HT. Variables predictive of survival in patients with coronary disease: Selection by univariate and multivariate analyses from clinical, electrocardiography, exercise, arteriographic, and quantitative angiographic evaluations. Circulation. 1979;59:421-430.
10. Apple FS, Murakami M, Panteghini M, et al. On behalf of the IFCC Committee on Standardization of Markers of Cardiac Damage. International survey on the use of cardiac markers. Clin Chem. 2001;47:587-588.
11. Alderman EL, Corley SD, Fisher LD, et al. CASS participating investigators and staff. Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). J Am Coll Cardiol. 1993;22:1141-1154.
12. Nobuyoshi M, Tanaka M, Nosaka H, et al. Progression of coronary atherosclerosis: Is coronary spasm related to progression? J Am Coll Cardiol. 1991;18:904-910.
13. Patti G, Pasceri V, Melfi R, et al. Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation. 2005;111:70-75.
14. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51:606-607.
15. Ryan TJ, Bauman WB, Kennedy JW, et al. Guidelines for percutaneous transluminal coronary angioplasty: A report of the ACC/AHA Task Force on assessment of diagnostic and therapeutic cardiovascular procedures. J Am Coll Cardiol. 1993;22:2033-2054.
16. Gall MA, Rossing P, Skott P, et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1991;34:655-661.
17. Mattock MB, Keen H, Viberti GC, et al. Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulindependent) diabetic patients. Diabetologia. 1988;31:82-87.
18. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet. 1988;2:530-533.
19. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 1989;32:219-226.
20. Feldt-Rasmussen B. Microalbuminuria, endothelial dysfunction and cardiovascular risk. Diabetes Metab. 2000;26:64-66.
21. Kario K, Matsuo T, Kobayashi H, et al. Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria. Arterioscler Thromb Vasc Biol. 1996;16:455-461.
22. Festa A, D'Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int. 2000;58:1703-1710.
23. Cirillo M, Lombardi C, Bilancio G, Chiricone D, Stellato D, De Santo NG. Urinary albumin and cardiovascular profile in the middle-aged population. Semin Nephrol. 2005;25:367-371.
24. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension. 2000; 35:898-903.
25. Pedrinelli R, Penno G, Dell'Omo G, et al. Microalbuminuria and transcapillary albumin leakage in essential hypertension. Hypertension. 1999;34:491-495.
26. Papaioannou GI, Seip RL, Grey NJ, et al. Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-Brachial Artery Reactivity Study). Am J Cardiol. 2004;94:294-299.
27. Goligorsky MS, Chen J, Brodsky S. Workshop: Endothelial cell dysfunction leading to diabetic nephropathy: Focus on nitric oxide. Hypertension. 2001;37:744-748.
28. Makino H, Doi K, Hiuge A, et al. Impaired flow-mediated vasodilatation and insulin resistance in type 2 diabetic patients with albuminuria. Diabetes Res Clin Pract. 2008;79:177-182.
29. Dogra G, Rich L, Stanton K, Watts GF. Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria. Diabetologia. 2001;44:593-601.
30. Baykan M, Erdogan T, Erem C, et al. The relationship between flow-mediated dilatation and left ventricular function in type 2 diabetic patients with microalbuminuria. Endocrine. 2006;30:197-202.
31. Silva RP, Cinse K, de Oliveira JM, Kubrusly M, Rodrigues Sobrinho CR, de Andrade PJ. Determination of microalbuminuria in hypertensive patients and in patients with coronary artery disease. Arq Bras Cardiol. 2008;90:99-103.
32. Barzilay JI, Peterson D, Cushman M, et al. The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: The Cardiovascular Health Study. Am J Kidney Dis. 2004;44:25-34.
33. Romundstad S, Holmen J, Hallan H, Kvenild K, Krüger O, Midthjell K. Microalbuminuria, cardiovascular disease and risk factors in a nondiabetic/nonhypertensive population. The Nord-Trondelag Health Study (HUNT, 1995-97), Norway. J Intern Med. 2002;252:164-172.
34. Diercks GF, Stroes ES, van Boven AJ, et al. Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation, in apparently healthy subjects. Atherosclerosis. 2002;163:121-126.
35. Cao JJ, Barzilay JJ, Peterson D, et al. The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: The Cardiovascular Health Study. Atherosclerosis. 2006;187:372-377.
36. Zouvanis M, Raal FJ, Joffe BI, Seftel HC. Microalbuminuria is not associated with cardiovascular disease in patients with homozygous familial hypercholesterolemia. Atherosclerosis. 1995; 113:289-292.
37. Kshirsagar AV, Bomback AS, Bang H, et al. Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004). Am J Cardiol. 2008;101:401-406.
38. Crook MA, Tutt P, Pickup JC. Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy. Diabetes Care. 1993;16:57-60.
39. Ortega O, Rodriguez I, Gallar P, et al. Significance of high C-reactive protein levels in pre-dialysis patients. Nephrol Dial Transplant. 2002;17:1105-1109.